Last $0.0020 USD
Change Today +0.0003 / 17.65%
Volume 50.5M
BMSN On Other Exchanges
Symbol
Exchange
OTC US
As of 5:20 PM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

bio-matrix scientific group (BMSN) Snapshot

Open
$0.0018
Previous Close
$0.0017
Day High
$0.0022
Day Low
$0.0016
52 Week High
03/7/14 - $0.0091
52 Week Low
11/27/13 - $0.0011
Market Cap
5.9M
Average Volume 10 Days
33.1M
EPS TTM
--
Shares Outstanding
3.0B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIO-MATRIX SCIENTIFIC GROUP (BMSN)

Related News

No related news articles were found.

bio-matrix scientific group (BMSN) Related Businessweek News

No Related Businessweek News Found

bio-matrix scientific group (BMSN) Details

Bio-Matrix Scientific Group, Inc., a development stage company, through its subsidiary, Regen BioPharma, Inc., intends to engage primarily in the development of regenerative medical applications. It develops HemaXellerate, a cellular drug to heal damaged bone marrow; and HemaXellerate I, which is a patient-specific composition of cells that have been demonstrated to repair damaged bone marrow and stimulate production of blood cells based on previous animal studies. The company is based in La Mesa, California.

3 Employees
Last Reported Date: 01/7/14

bio-matrix scientific group (BMSN) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $290.0K
Compensation as of Fiscal Year 2013.

bio-matrix scientific group (BMSN) Key Developments

Bio-Matrix Scientific Group, Inc. announced delayed annual 10-K filing

On 12/30/2013, Bio-Matrix Scientific Group, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Bio-Matrix Scientific Group, Inc. announced delayed 10-Q filing

On 05/14/2013, Bio-Matrix Scientific Group, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Entest Biomedical, Inc. and Bio-Matrix Scientific Group, Inc. Enter into Settlement Agreement with 18KT.TV LLC

On February 3, 2011, a complaint was filed in the U.S. District Court Middle District of the State of Pennsylvania against Entest Biomedical, Inc., David Koos (the company’s Chairman and CEO) and Bio-Matrix Scientific Group, Inc. by 18KT.TV LLC (Plaintiffs) seeking to recover general damages from the company in excess of $125,000. The complaint alleged breach of contract and unjust enrichment relating to an investor relations contract executed by the company and Craig Fischer (on behalf of 18KT.TV LLC). On March 1, 2013 a settlement agreement and mutual general release was entered into by and between the plaintiffs and the company. Pursuant to the agreement: The plaintiffs irrevocably release and forever unconditionally discharge the company of and from any and all actions, causes of action, suits, claims, debts, dues, accounts, bonds, covenants, charges, complaints, contracts, agreements, promises, judgments and demands whatsoever, in law or in equity. The company irrevocably releases and forever unconditionally discharges the plaintiffs  of and from any and all actions, causes of action, suits, claims, debts, dues, accounts, bonds, covenants, charges, complaints, contracts, agreements, promises, judgments and demands whatsoever, in law or in equity. The company shall cause to be issued to 18KT.TV LLC 41,000,000 of the company’s newly issued restricted common shares.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMSN:US $0.00 USD +0.0003

BMSN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BMSN.
View Industry Companies
 

Industry Analysis

BMSN

Industry Average

Valuation BMSN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIO-MATRIX SCIENTIFIC GROUP, please visit www.bmsn.us. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.